Purpose
The purpose of the Canadian National Vaccine Safety Network (CANVAS) COVID project is to track vaccine safety and adverse effects after a COVID-19 vaccine. This project is coordinated by the Vaccine Evaluation Centre (VEC) and led by Dr. Julie Bettinger, Investigator, BC Children’s Hospital, and Professor, Division of Infectious Diseases, VEC, Department of Pediatrics, UBC. There are 400,000 volunteer participants per vaccine, across B.C., Yukon, Alberta, Ontario, Quebec, Nova Scotia, and P.E.I., and the control group consists of 50,000 unvaccinated people. In total, there are 1.5 million Canadians participating in this study.
Our Involvement
- Phase I: Coalescing data from 30+ REDCap projects into one central database on the FoM Digital Solutions Oracle APEX platform.
- Phase II: Improving and automating quality assurance (QA) activities, by building infrastructure security access, for statisticians at VEC so they can perform the data analysis and cleansing.
- Phase III: We want to offer the same data analysis and visualization capability to each province to minimize the workload and dependency on VEC.
Services Used
Electronic Data Collection
Data Applications
“As the CANVAS-COVID project quickly surpassed our enrollment expectations, FoM Digital Solutions Research Technology swiftly pulled together an expert team to work with us to design and build a custom solution to meet our database needs. The COVID-19 vaccine rollout across Canada was, and still is, very dynamic and the Research Technology team has easily adapted to these ever-changing needs. They have been a life-saver to this project!”
-Kim Marty, Data Manager, Vaccine Evaluation Centre
Publications
Sadarangani, M., Soe, P., Shulha, H.P., Valiquette, L., Vanderkooj, O.G., Kellner, J., … Bettinger, J.A. (2022). The Canadian National Vaccine Safety Network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada. BMJ Open, 22(11), p.1553-1564. https://doi.org/10.1016/S1473-3099(22)00426-1